Skip to main content


Cost-Effectiveness Research

Featured

Videos
Ali Khaki, MD, discusses results from a cost-effectiveness analysis comparing neoadjuvant immune checkpoint inhibition with cisplatin-based chemotherapy for muscle-invasive…
Videos
Vidit Sharma, MD, discusses results from a cost-effectiveness analysis comparing pembrolizumab with radical cystectomy…
News
Compared with selective internal radiotherapy, sorafenib is not unlikely cost-effective for HCC in the United States.
News
Targeted BRCA or multiple gene screening is cost-effective for preventing breast and ovarian cancer, according to a…
News
While the use of doublet therapy for treating patients with metastatic BRAF variant colorectal cancer is associated…
Back to Top